Another promising Alzheimer’s drug trial ends in failure: ‘This one hurts’
It’s another devastating blow in the search for a treatment for patients living with Alzheimer’s disease. Pharmaceutical giant Biogen and its Japanese partner Eisai announced Thursday they…